NASDAQ$TNDM
Tandem Diabetes Care Inc · Q1 2020 earnings
Q1 2020 earnings · · Investor relations
Briefing
Tandem Diabetes Care reported financial results with sales increasing and gross margin remaining consistent compared to the same period last year. The company provided sales guidance for the second quarter of 2020 and withdrew its financial guidance for the year ending December 31, 2020, due to the COVID-19 pandemic.
Tandem Diabetes Care reported a 48% increase in sales to $97.9 million and a gross margin of 51% for the first quarter of 2020. Worldwide pump shipments increased by 18% compared to the same period in 2019. However, due to the COVID-19 pandemic, the company withdrew its full-year financial guidance.
- Worldwide pump shipments increased 18 percent to 17,378 pumps.
- Sales increased 48 percent to $97.9 million.
- Gross margin was 51 percent for both periods.
- Adjusted EBITDA improved to 4 percent of sales.
Headline financials
Revenue & EPS history
Tandem Diabetes · Revenue · Quarterly
$97.9M
Revenue by segment
Tandem Diabetes · $80.7M total across 1 segment · Q3 2022
- Pump Sales$80.7M—100.0%
Forward guidance
For the quarter ending June 30, 2020, sales are estimated to be at least $85 million, including international sales of approximately $10 million. For the year ending December 31, 2020, the Company has withdrawn its financial guidance.
Tailwinds
- Sales are estimated to be at least $85 million for the quarter ending June 30, 2020.
- International sales are expected to be approximately $10 million for the quarter ending June 30, 2020.
- Company anticipates domestic growth compared to the second quarter of last year.
- Positive customer feedback on t:slim X2 with Control-IQ technology.
- Focus on near term guidance.
Headwinds
- Annual financial guidance for the year ending December 31, 2020 has been withdrawn.
- Unpredictable impact of the current pandemic on business operations.
- Second quarter sales guidance is lower than Q1 2020 sales.
- Potential impact of COVID-19 on international sales.
- Uncertainty associated with predicting any future adjustments to GAAP financial measures.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2020
-0.4%
Avg return
Earnings day
-2.2%
Avg return
5 days after
+3.5%
Avg return
30 days after
55%
27 / 49 earnings
Positive
+32.8%
Q4 2025
Best reaction
-63.6%
Q3 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +7.6% | -23.6% | +5.0% | |
| Q4 2025 | +32.8% | +40.4% | +34.0% | |
| Q3 2025 | +22.0% | +35.5% | +56.9% | |
| Q1 2025 | +18.6% | +26.5% | +17.6% | |
| Q4 2024 | -35.2% | -42.0% | -42.6% | |
| Q3 2024 | +0.6% | -5.3% | -9.1% | |
| Q2 2024 | +12.7% | +17.3% | +17.6% | |
| Q1 2024 | +23.5% | +21.5% | +41.5% | |
| Q4 2023 | +6.1% | +22.5% | +28.4% | |
| Q3 2023 | -12.1% | -11.5% | +22.5% | |
| Q2 2023 | +2.8% | -13.4% | -14.3% | |
| Q1 2023 | -2.9% | -13.4% | -35.9% | |
| Q4 2022 | -2.1% | -8.0% | +8.0% | |
| Q3 2022 | -34.3% | -31.5% | -23.7% | |
| Q2 2022 | -14.0% | -11.8% | -34.3% | |
| Q1 2022 | -16.4% | -27.6% | -33.8% | |
| Q4 2021 | -0.3% | +7.6% | +7.6% | |
| Q3 2021 | -4.9% | -2.6% | -4.3% | |
| Q2 2021 | +4.7% | +2.6% | +8.8% | |
| Q1 2021 | -5.6% | -11.9% | -5.8% | |
| Q4 2020 | +3.5% | +4.4% | -10.0% | |
| Q3 2020 | +1.5% | -11.4% | -17.9% | |
| Q2 2020 | +1.8% | +3.0% | +10.1% | |
| Q1 2020 | +7.6% | +13.7% | +11.5% | |
| Q4 2019 | -11.4% | -15.2% | -34.7% | |
| Q3 2019 | -6.5% | -8.0% | +2.2% | |
| Q2 2019 | +2.9% | -1.5% | +14.2% | |
| Q1 2019 | -5.8% | +6.3% | +9.2% | |
| Q4 2018 | +27.9% | +43.2% | +31.8% | |
| Q3 2018 | +6.3% | -2.2% | -2.1% | |
| Q2 2018 | +7.7% | +29.0% | +59.9% | |
| Q1 2018 | +7.9% | +7.7% | +96.4% | |
| Q4 2017 | +23.1% | +25.0% | +57.0% | |
| Q3 2017 | -3.4% | -6.4% | +2.7% | |
| Q2 2017 | -17.3% | -39.4% | +8.7% | |
| Q1 2017 | -11.8% | -10.5% | -22.4% | |
| Q4 2016 | -19.1% | -10.6% | -51.1% | |
| Q3 2016 | -63.6% | -66.9% | -63.2% | |
| Q2 2016 | -13.9% | -18.8% | -8.4% | |
| Q1 2016 | +7.1% | — | — | |
| Q4 2015 | +11.9% | — | — | |
| Q3 2015 | +20.6% | — | — | |
| Q2 2015 | +8.9% | — | — | |
| Q1 2015 | +1.7% | — | — | |
| Q4 2014 | -3.1% | — | — | |
| Q3 2014 | -11.0% | — | — | |
| Q2 2014 | +11.4% | — | — | |
| Q1 2014 | -11.7% | — | — | |
| Q4 2013 | +4.0% | — | — | |
| Q2 2013 | — | — | — | |
| Q1 2013 | — | — | — | |
| Q4 2012 | — | — | — | |
| Q3 2012 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro